ClinicalTrials.gg
Not yet recruitingNCT07946835Updated Nov 18, 2026

The Effects of Virtual Reality-Based Relaxation on Postoperative Symptoms and Patient Satisfaction Among Adolescents Undergoing Emergency Surgery

An interventional study of Virtual Reality-Based Relaxation Exercises in Symptom Management, Postoperative Pain Management and Perioperative Anxiety, sponsored by Dokuz Eylul University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Dokuz Eylul University · Not applicable, Interventional, and Supportive care

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 1,104 studies in Pain, Postoperative with a site in Turkey — 267 open to participants now, 301 under way, none of them phase 3. Pain, Postoperative · Turkey.

Planned enrollment
527th of 889
60 · median 70
Started
2026
with 226 others
No phase
820 of 1,104
220 open now
Primary completion
2027-04
later than 239 of 300 live
Registered
1,095th of 1,104
by date

Among the 1,104 studies in Pain, Postoperative with a site in Turkey, this one is the 527th largest by planned enrollment of the 889 interventional ones that give a count, is one of 227 that started in 2026, is one of 820 with no phase, reaches primary completion later than 239 of the 300 other live ones, and was the 1,095th registered.

Pain, Postoperative

5,671 studies on the registry are indexed under Pain, Postoperative; 1,238 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

267 of the 1,104 studies in Pain, Postoperative with a site in Turkey are open now. Recruiting first, the newest first:

262 more — sign in →

All 267 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 240 (35%) set no upper age limit and 328 (48%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 12 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,104 studies in Pain, Postoperative with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the effects of virtual reality-based progressive relaxation exercises on surgery-related symptoms and patient satisfaction among adolescents undergoing emergency surgery. Specifically, the study will investigate the effects of these exercises on preoperative and postoperative anxiety levels, pain intensity scores, nausea and vomiting scores, time to mobilization (hours), total length of hospital stay (hours), and patient satisfaction.

Read the detailed description

The aim of this study is to evaluate the effects of virtual reality-based progressive relaxation exercises on surgery-related symptoms and patient satisfaction in adolescents undergoing emergency surgical procedures. Specifically, the study will examine the effects of this intervention on preoperative and postoperative anxiety levels, pain intensity, nausea and vomiting severity, time to first mobilization (hours), total length of hospital stay (hours), and patient satisfaction.

03

Conditions studied

  • Symptom Management
  • Postoperative Pain Management
  • Perioperative Anxiety
  • Rehabilitation Exercise

Browse trials for

Keywords

  • virtual reality,
  • emergency surgery
  • symptom management
  • relaxation therapy
04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Inclusion Criteria:
  • Adolescents aged 12-18 years who voluntarily agree to participate in the study,
  • Undergoing surgery for the first time,
  • Scheduled to undergo emergency surgery within 24 hours of hospital admission (appendicitis, ovarian torsion, testicular torsion, or Meckel's diverticulum),
  • Having no chronic diseases (e.g., diabetes, hypertension, asthma, cerebral palsy, epilepsy, cystic fibrosis, etc.),
  • Having no visual, hearing, or physical disabilities,
  • Being oriented to person, place, and time,
  • Having no cognitive impairment that would affect their ability to express themselves,
  • Adolescents for whom written has been obtained from both the adolescent and their parent.

Exclusion Criteria:

  • Adolescents who do not complete all stages of the study,
  • Adolescents who are admitted to the intensive care unit after surgery,
  • Adolescents whose surgery is postponed beyond the first 24 hours,
  • Adolescents who undergo surgery due to perforated appendicitis,
  • Adolescents diagnosed with migraine, vertigo, or similar conditions,
  • Adolescents who experience hemodynamic instability when wearing the VR headset.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Intervention Group: Virtual Reality

    Adolescents and their parents will be informed about the study, and written informed consent will be obtained. Baseline data will be collected using the Adolescent Descriptive Characteristics Form, Vital Signs Monitoring Form, Visual Analog Scale (VAS), and Spielberger State Anxiety Inventory (STAI-S). Participants will receive instructions on VR headset use and relaxation exercises. Before surgery, vital signs, pain, and anxiety will be reassessed. Postoperatively, vital signs, pain, anxiety, and nausea (BARF scale) will be evaluated. At the fourth postoperative hour, following adequate recovery from anesthesia, the VR-based relaxation intervention will be administered. All clinical outcomes will be reassessed at the sixth postoperative hour. Before discharge, patient satisfaction (VAS-S), time to first mobilization, and length of hospital stay will be recorded.

    Other: Virtual Reality-Based Relaxation Exercises

  • No intervention
    Control Group: Standard Care

    During the preoperative period, adolescents and their parents will be informed about the surgical process, and appropriate measures will be taken to ensure patient safety. Adolescents and their parents will also be informed about the study, and written informed consent will be obtained from both parties. During the initial face-to-face interview, data will be collected using the Adolescent Descriptive Characteristics Form, Vital Signs Monitoring Form, Visual Analog Scale (VAS), and Spielberger State-Trait Anxiety Inventory - State Version (STAI-S). Demographic and clinical data will be obtained from the adolescents, their parents, and medical records. Before surgery, vital signs, pain intensity, and state anxiety levels will be reassessed. At the fourth postoperative hour, vital signs, pain intensity, state anxiety, and nausea will be assessed using the BARF scale, while routine nursing care will be provided. At the sixth postoperative hour, these clinical outcomes will be reassessed.

Interventions

  • OtherVirtual Reality-Based Relaxation Exercises

    The virtual reality (VR) intervention was implemented using an Oculus Quest 2 headset, selected to ensure patient safety and ease of use. The device is rechargeable, operates independently without requiring a computer connection, weighs 503 g, and is secured to the user's head using adjustable, soft straps. Its hand-tracking feature enables participants to interact naturally with virtual environments using their own hands, without the need for handheld controllers. The VR-based relaxation program lasts 16 minutes and incorporates rhythmic breathing, controlled exhalation, and progressive muscle relaxation exercises. The progressive muscle relaxation component targets several muscle groups, including the arms and hands, neck, chest and abdomen, legs and hips, back and shoulders, eyes and head, and feet and lower legs.

06

What researchers measure

Primary outcomes

  1. Preoperative Anxiety Level

    Anxiety will be assessed using the Spielberger State Anxiety Inventory (STAI-S), a 20-item scale with total scores ranging from 20 to 80, with higher scores indicating higher levels of anxiety. Two assessments will be conducted during the preoperative period: the first immediately upon the patient's arrival at the surgical ward and the second 30 minutes before transfer to the operating room.

    Time frame: 6 months

  2. Postoperative Anxiety Level

    Postoperative anxiety will be assessed on postoperative day 0 using the Spielberger State Anxiety Inventory (STAI-S), a 20-item self-report instrument scored on a 4-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate greater levels of postoperative anxiety. Assessments will be conducted at two time points: 4 and 6 hours after surgery (postoperative day 0).

    Time frame: 6 months

  3. Postoperative Pain Intensity

    Postoperative pain intensity will be assessed on postoperative day 0 (POD 0) using a 10-cm Visual Analog Scale (VAS), with scores ranging from 0 to 10. A score of 0 indicates no pain, whereas a score of 10 represents the worst imaginable pain. Assessments will be performed at 4 and 6 hours after surgery.

    Time frame: 6 months

Secondary outcomes

  1. Postoperative Nausea Severity

    Postoperative nausea severity will be assessed using the Baxter Retching Faces (BARF) Scale, with scores ranging from 0 to 10. A score of 0 indicates no nausea, whereas a score of 10 represents the most severe nausea. Assessments will be conducted at two time points: 4 and 6 hours after surgery.

    Time frame: 6 months

  2. Postoperative Length of Hospital Stay

    Total duration of postoperative hospitalization, measured in hours from the completion of the surgical procedure until the adolescent patient is formally discharged from the hospital.

    Time frame: 6 months

  3. Patient satisfaction level

    Visual Analog Scale for Satisfaction (VAS-S): Patient satisfaction with nursing care will be assessed using a 10-cm visual analog scale ranging from 0 (not satisfied at all) to 10 (completely satisfied), with higher scores indicating greater satisfaction. The assessment will be performed at the 6th postoperative hour on the day of surgery (POD 0).

    Time frame: 6 months

  4. At the First Postoperative Mobilization Session

    The total duration (in minutes) of active ambulation performed by the adolescent patient during the first postoperative mobilization session on postoperative day 0 (POD 0).

    Time frame: 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Apr 2027, 4 months later.

Of 2,101 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 4 months is below that.

Counting every sponsor, half of 2,114 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2026
First posted
Nov 18, 2026
StartEst.
Nov 20, 2026
Primary completionEst.
Apr 10, 2027
CompletionEst.
Aug 10, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07946835
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Aynur Çakmak (Clinical Nurse Specialist, Dokuz Eylul University) — Principal investigator
First posted
Nov 18, 2026
Start date
Nov 20, 2026 (estimated)
Primary completion
Apr 10, 2027 (estimated)
Completion
Aug 10, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Aynur Çakmak, PhD Student
Contact
aynurcakmak3@gmail.com
+90 555 689 43 12
Fatma Vural, Professor
Contact
fatma.vural@deu.edu.tr
+90 532 476 37 81

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion